Talks
Implantable & Ultra-Long-Acting GLP1RA
April 27, 2026
Delay in Statin Therapy in T2D
April 27, 2026
VESALIUS-CV: Reduced CV Risk in T2D with Evolocumab
April 27, 2026
Once-Weekly Insulin Icodec (Awiqli) Approved for T2D
April 27, 2026
Improved Glycemic Control with CGM
April 26, 2026
Triple-Agonist UBT251 Data
March 26, 2026
GLP-1RA Cessation: CV Risk
March 26, 2026
GLP-1RA Cessation: T1D Glycemic Control
March 26, 2026
GLP-1RA and SUD
March 26, 2026
Trends in National Expenditure on Diabetes Therapies
March 26, 2026
GLP1-RAs & Vision-Related Issues
March 26, 2026
GLP-1RA In T1D
March 22, 2026
Wegovy 7.2mg Approved
March 22, 2026
FreeDM2 Trial Results
March 21, 2026
TRANSCEND-T2D Trial Results
March 21, 2026
Fin.
June 14, 2022
Posters
June 13, 2022
Glucagon
June 13, 2022
PTC Debate
June 13, 2022
TRT
June 13, 2022
Debate
June 12, 2022
Thyroid
June 12, 2022
SGLT2i
June 12, 2022
PRA
June 12, 2022
Underprescribing
June 12, 2022
Debate
June 11, 2022
Statins
June 11, 2022
Poster
June 11, 2022
Achievement Award
June 11, 2022
First Day!
June 11, 2022
Close button
Why are you reporting this TALK?